Medically reviewed by Sanja Jelic, MD Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory (lung) ...

Chronic obstructive pulmonary disease (COPD) is among the most common breathing conditions. It's the result of damaged lung tissue.

The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...

Chronic obstructive pulmonary disease, or COPD, not only leads to breathing ... The other type is pulmonary emphysema which causes inflammation in the alveoli, about 0.3 millimeters in diameter ...

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...

The global COPD and asthma diagnostic and monitoring device market accounted for $4,953.60 million in 2019, and is expected to reach $8,202.62 million by 2027, registering a CAGR of 6.3% from 2020 to ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils Approval marks the first new treatment approach for ...

Thus, our results suggest that overweight during this early period of life is an indicator of risk for the development of ...

A new study links childhood overweight and obesity to higher COPD risk, stressing early weight management for lung health.

COPD is a chronic respiratory disease that damages the lungs and causes progressive lung function decline and is the fourth leading cause of death worldwide. Symptoms include persistent cough ...